- Home
- MHF vs QSI Comparison
MHF vs QSI Comparison
Compare MHF & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MHF | QSI |
|---|---|---|
| Founded | 1988 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.1M | 165.6M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | MHF | QSI |
|---|---|---|
| Price | $6.95 | $0.82 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 57.1K | ★ 2.5M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 4.29% | N/A |
| EPS Growth | N/A | ★ 28.17 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $618.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.63 | $0.69 |
| 52 Week High | $7.64 | $3.10 |
Technical Indicators
Market Signals| Indicator | MHF | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 55.07 | 52.62 |
| Support Level | $6.84 | $0.81 |
| Resistance Level | $7.05 | $1.04 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 72.22 | 96.60 |
Price Performance
Historical ComparisonAbout MHF Western Asset Municipal High Income Fund Inc.
Western Asset Municipal High Income Fund Inc is a diversified closed-end management investment company. The company's objective is to seek high current income exempt from federal income taxes. It invests predominantly in intermediate and long-term municipal debt securities issued by state and local governments.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.